Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
for Newly Diagnosed Glioblastoma
Drug: Relatlimab
1 location in Durham
Sponsor: Duke University
Sex: All·Age: 18+
Code: NCT06816927·Phase 2·Recruiting
North Carolina has 2,930 paid clinical trials enrolling now across cities including Durham, Chapel Hill and Winston-Salem. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in North Carolina include Duke University Medical Center, UNC Health and Wake Forest Baptist, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .